Ajax-Loading

Shionogi & Co. Ltd. - Research and Development

Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Research-and-Development" stands at 104.07 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 06/30/2024.

Shionogi & Co. Ltd.'s first quarter result of 24.89 Billion JPY for the item "Research and Development" represents a decrease of -14.66 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Shionogi & Co. Ltd.'s first quarter result of 24.89 Billion JPY for the item "Research and Development" represents a decrease of -15.44 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s first quarter result of 104.07 Billion JPY for the item "Research and Development" represents a decrease of -4.18 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.81 percent compared to the value the year prior.
The 1 year change in percent is -2.81.
The 3 year change in percent is 28.80.
The 5 year change in percent is 24.95.
The 10 year change in percent is 112.95.

The Serie's long term average value is 96.50 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 7.84 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2015, to it's latest available value, on 06/30/2025, is +112.95%.
The Serie's change in percent from it's maximum value, on 03/31/2018, to it's latest available value, on 06/30/2025, is -56.60%.

Research and Development for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Research and Development905,699,262,464.00
LogoJohnson & Johnson - Research and Development486,508,953,600.00
LogoAbbVie Inc - Research and Development399,570,305,024.00
LogoRoche Holding AG - Research and Development317,433,206,677.55
LogoAstraZeneca PLC - Research and Development280,205,508,085.11